Viewing Study NCT03403634


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-03-08 @ 11:02 PM
Study NCT ID: NCT03403634
Status: COMPLETED
Last Update Posted: 2022-03-02
First Post: 2018-01-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Carcinoma in the Liver View
None Recurrent Colorectal Carcinoma View
None Stage IV Colorectal Cancer AJCC v7 View
None Stage IVA Colorectal Cancer AJCC v7 View
None Stage IVB Colorectal Cancer AJCC v7 View
Keywords: